Rifaximin: profile and news






Salix Pharmaceuticals Reports 1Q2006 Results  May 4, 2006
XIFAXAN(R) (rifaximin) tablets 200 mg are indicated for the treatment of patients (greater than or equal to 12 years of age) with travelers' diarrhea caused by ... - Genetic Engineering News,

Salix Announces Completion of OsmoPrep(TM) versus Liquid Bowel ...  Apr 19, 2006
Salix also markets COLAZAL(R) (balsalazide disodium) Capsules 750 mg, XIFAXAN(R) (rifaximin) tablets 200 mg, VISICOL(R) Tablets (sodium phosphate monobasic ... - Genetic Engineering News,


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org